Neptis

ORA (Optimized Radiochemical Applications) is a leading developer and manufacturer of automated synthesis systems for the production of radiopharmaceuticals used in Positron Emission Tomography (PET). The company is best known for its NEPTIS® platform, which provides a versatile and modular solution for the synthesis of a wide range of PET tracers, including [18F]FDG and more complex molecules. ORA's technology is designed to streamline the radiochemistry process, ensuring high yields, reproducibility, and compliance with Good Manufacturing Practice (GMP) standards. Beyond hardware, the company offers comprehensive support, including software development, cassette design, and chemical process optimization for research and clinical applications. ORA serves a global clientele of hospitals, research centers, and commercial radiopharmacies.